Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Preliminary results Director departure Quarterly results CC transcript
|
ANGIODYNAMICS INC (ANGO)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/04/2023 |
8-K
| Quarterly results |
07/12/2023 |
8-K
| Quarterly results |
01/05/2023 |
8-K
| Quarterly results |
10/06/2022 |
8-K
| Quarterly results |
07/12/2022 |
8-K
| Quarterly results |
04/07/2022 |
8-K
| Quarterly results |
01/06/2022 |
8-K
| Quarterly results |
07/13/2021 |
8-K
| Quarterly results |
01/07/2021 |
8-K
| Quarterly results |
09/29/2020 |
8-K
| Quarterly results |
07/16/2020 |
8-K
| Quarterly results |
04/07/2020 |
8-K
| Quarterly results |
01/07/2020 |
8-K
| Quarterly results |
10/03/2019 |
8-K
| Quarterly results |
07/10/2019 |
8-K
| Quarterly results |
04/02/2019 |
8-K
| Quarterly results |
01/04/2019 |
8-K
| Quarterly results |
09/27/2018 |
8-K
| Quarterly results |
07/11/2018 |
8-K
| Quarterly results |
03/29/2018 |
8-K
| Quarterly results |
01/04/2018 |
8-K
| Quarterly results |
09/28/2017 |
8-K
| Quarterly results |
03/30/2017 |
8-K
| Form 8-K - Current report |
01/06/2017 |
8-K
| Form 8-K - Current report |
10/05/2016 |
8-K
| Form 8-K - Current report |
04/07/2016 |
8-K
| Quarterly results |
01/07/2016 |
8-K
| Quarterly results |
10/08/2015 |
8-K
| Quarterly results |
07/17/2015 |
8-K
| Quarterly results |
04/09/2015 |
8-K
| Quarterly results |
01/08/2015 |
8-K
| Quarterly results |
10/09/2014 |
8-K
| Quarterly results |
07/23/2014 |
8-K
| Quarterly results |
04/09/2014 |
8-K
| Quarterly results
Docs:
|
"AngioDynamics Reports Fiscal 2014 Third Quarter Financial Results ● Net sales increase 8% over prior year to $88.2 million ● GAAP income per share of $0.14; Non-GAAP adjusted net income, excluding amortization, of $0.16 per share ● Adjusted EBITDA of $14.6 million ● Company’s revenue guidance to $351 million- $355 million for FY14; Adjusted EPS, excluding amortization, of $0.60-$0.63 ALBANY, N.Y., – AngioDynamics , a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported financial results for the fiscal 2014 third quarter ended February 28, 2014. “Our strong top line performance marks the fourth consecutive quarter of improved sales results, reflecting continued market..." |
|
|
|
|